Universitaetsmedizin Greifswald KöR
- Address
- lock Available on a paid plan
Nervous System Disease Research
At Universitaetsmedizin Greifswald KöR, clinical research is focused on Nervous System Diseases, with particular attention to chronic migraine. The studies in this area are aimed at understanding how to better prevent and manage recurring migraine symptoms in adults.
- Evaluating a new treatment approach for chronic migraine prevention
- Assessing treatment effectiveness in reducing monthly migraine days
This research supports efforts to improve symptom control and expand therapeutic options for people living with long-term migraine conditions.
Headache and Migraine Studies
The Klinik und Poliklinik für Neurologie is involved in trials centered on chronic migraine, a disabling condition within the broader field of neurological disorders. These studies are designed to compare active treatment with placebo and determine whether new preventive strategies can lessen the burden of frequent migraine attacks.
- Testing a therapy intended to reduce the number of migraine days each month
- Exploring better ways to prevent persistent migraine symptoms in adults
The work at this site reflects a clear interest in improving both the effectiveness and the practical management of migraine care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 29 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Dianthus Therapeutics Inc.1active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Genmab A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universitaetsmedizin Greifswald KöR
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Botulinum Toxin Type A in Chronic Migraine Prevention in Adults: A Randomized, Double-Blind, Placebo-Controlled Study | Ipsen Innovation | Phase III | Not Recruiting | Mar 2024 | — |
IMP list
lock Showing 1 of 29 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 3 | Unknown | 2024-11-14 | 2026-07-14 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.